GlaxoSmithKline Reportedly Settles 700 Avandia Cases

/by

Drug maker GlaxoSmithKline has settled some 700 cases involving its diabetes drug Avandia, according to a Bloomberg news report. The Avandia lawsuits alleged that the drug caused them to suffer heart attacks and strokes. The settlement is reported to be around $60 million for the 700 claimants. That does not resolve all of the Avandia lawsuits, however. There are some 9,000 more claims that have not been filed under an agreement between the claimants and GlaxoSmithKline lawyers.
The first Avandia trial is due to begin this July in state court in Philadelphia.

Kevin Dugan
Latest posts by Kevin Dugan (see all)